PureTech Health (LON:PRTC) Stock Crosses Below 50-Day Moving Average – Should You Sell?

PureTech Health plc (LON:PRTC)’s share price passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 149.88 ($1.89) and traded as low as GBX 145.80 ($1.84). PureTech Health shares last traded at GBX 146.40 ($1.85), with a volume of 137,820 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reissued a “buy” rating and issued a GBX 455 ($5.74) price target on shares of PureTech Health in a research note on Monday, December 16th.

PureTech Health Stock Performance

The company has a debt-to-equity ratio of 45.82, a quick ratio of 2.51 and a current ratio of 3.68. The firm’s 50 day simple moving average is GBX 149.88 and its 200-day simple moving average is GBX 155.71. The company has a market cap of £434.95 million, a price-to-earnings ratio of -5.94 and a beta of 1.02.

PureTech Health Company Profile

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.